A framework for future national pediatric pandemic respiratory disease severity triage: The HHS pediatric COVID-19

Timothy Bergquist1, Marie Wax2, Tellen D Bennett3

  • 1Sage Bionetworks, Seattle, WA, USA.

Insights

A federal challenge developed computational models to identify children at risk for severe COVID-19 outcomes. This initiative aims to improve resource allocation during public health emergencies.

Area of Science:

  • Computational epidemiology
  • Pediatric infectious diseases
  • Public health informatics

Background:

  • COVID-19 remains a significant burden on the pediatric population due to persistent incidence and incomplete vaccination.
  • Identifying at-risk pediatric patients for severe COVID-19 is crucial for effective healthcare resource allocation during surges.
  • A lack of validated, nationwide computational tools hinders proactive risk identification in children.

Purpose of the Study:

  • To develop computational models for identifying pediatric patients at risk of severe COVID-19 outcomes.
  • To address two key clinical questions: risk for hospitalization in outpatients and risk for mechanical ventilation or cardiovascular interventions in hospitalized children.
  • To leverage real-world data from the National COVID Cohort Collaborative (N3C).

Main Methods:

  • A multi-agency, coordinated computational challenge was launched by HHS ASPR BARDA.
  • Fifty-five computational models were evaluated across two distinct tasks.
  • The National COVID Cohort Collaborative (N3C) provided the real-world data for model development and evaluation.

Main Results:

  • Two winning models and three honorable mentions were selected from the evaluated submissions.
  • The challenge successfully demonstrated the potential of computational modeling in addressing critical public health questions.
  • This initiative represents a novel federal approach to leveraging data and competition for pandemic response.

Conclusions:

  • The computational challenge provides a successful framework for government, research, and data repositories to collaborate on solutions during public health crises.
  • This approach can accelerate the development and validation of tools for identifying at-risk pediatric populations.
  • Future efforts can build upon this model to enhance preparedness and response to infectious disease threats.
Abstract

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
624
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
263
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
155
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
209
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
231
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K